Results 71 to 80 of about 1,834,114 (325)

Bridging the gap: Multi‐stakeholder perspectives of molecular diagnostics in oncology

open access: yesMolecular Oncology, EarlyView.
Although molecular diagnostics is transforming cancer care, implementing novel technologies remains challenging. This study identifies unmet needs and technology requirements through a two‐step stakeholder involvement. Liquid biopsies for monitoring applications and predictive biomarker testing emerge as key unmet needs. Technology requirements vary by
Jorine Arnouts   +8 more
wiley   +1 more source

A Component-Based Approach to Early Warning Systems: A Theoretical Model

open access: yesApplied Sciences
Natural hazards pose an increasing threat to society, necessitating the development of effective early warning systems (EWSs). This paper explores their critical role in mitigating the impacts of natural hazards.
Daniel Chovanec   +5 more
doaj   +1 more source

EVALUATION OF THE FINANCIAL POSITION OF THE ENTERPRISE AND DETERMINATION OF THE OPTIMAL MODEL OF THE PROBABILITY OF BANKRUPTCY

open access: yesСтратегические решения и риск-менеджмент, 2015
The article deals with the financial analysis of the companies in bankruptcy proceedings. Using the principle of invariance of factors in predicting the functions of financial analysis, it was possible to assess the parameters and structure of the ...
A. V. Babanov
doaj   +1 more source

Integrated genomic and proteomic profiling reveals insights into chemoradiation resistance in cervical cancer

open access: yesMolecular Oncology, EarlyView.
A comprehensive genomic and proteomic analysis of cervical cancer revealed STK11 and STX3 as a potential biomarkers of chemoradiation resistance. Our study demonstrated EGFR as a therapeutic target, paving the way for precision strategies to overcome treatment failure and the DNA repair pathway as a critical mechanism of resistance.
Janani Sambath   +13 more
wiley   +1 more source

Adaptaquin is selectively toxic to glioma stem cells through disruption of iron and cholesterol metabolism

open access: yesMolecular Oncology, EarlyView.
Adaptaquin selectively kills glioma stem cells while sparing differentiated brain cells. Transcriptomic and proteomic analyses show Adaptaquin disrupts iron and cholesterol homeostasis, with iron chelation amplifying cytotoxicity via cholesterol depletion, mitochondrial dysfunction, and elevated reactive oxygen species.
Adrien M. Vaquié   +16 more
wiley   +1 more source

Intelligent management of an innovative oil and gas producing company under conditions of the modern system crisis [PDF]

open access: diamond, 2023
Maxim Krasnyuk   +4 more
openalex   +1 more source

Patient‐specific pharmacogenomics demonstrates xCT as predictive therapeutic target in colon cancer with possible implications in tumor connectivity

open access: yesMolecular Oncology, EarlyView.
This study integrates transcriptomic profiling of matched tumor and healthy tissues from 32 colorectal cancer patients with functional validation in patient‐derived organoids, revealing dysregulated metabolic programs driven by overexpressed xCT (SLC7A11) and SLC3A2, identifying an oncogenic cystine/glutamate transporter signature linked to ...
Marco Strecker   +16 more
wiley   +1 more source

Home - About - Disclaimer - Privacy